Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" / Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Cappello, Milena; Scalvenzi, Massimiliano. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - (2020). [10.1016/j.jaad.2020.03.124]

Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"

Villani, Alessia;Costa, Claudia;Fabbrocini, Gabriella;Cappello, Milena;Scalvenzi, Massimiliano
2020

2020
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" / Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Cappello, Milena; Scalvenzi, Massimiliano. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - (2020). [10.1016/j.jaad.2020.03.124]
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" / Villani, Alessia; Costa, Claudia; Fabbrocini, Gabriella; Cappello, Milena; Scalvenzi, Massimiliano. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - (2020). [10.1016/j.jaad.2020.03.124]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/806298
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact